Results 101 to 110 of about 174,143 (324)

Maximal subgroups of finite classical groups and their geometry

open access: yesLe Matematiche, 2004
We survey some recent results on maximal subgroups of finite classical groups.
Antonio Cossidente
doaj  

Green’s relations for 2 × 2 matrices over linearly ordered abelian groups [PDF]

open access: yesProceedings of the Estonian Academy of Sciences
We consider semigroups of 2 × 2 matrices over linearly ordered abelian groups with respect to multiplication, which is defined similarly to tropical algebra. We study Green’s relations on such semigroups.
Marilyn Kutti, Valdis Laan
doaj   +1 more source

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan   +22 more
wiley   +1 more source

Theoretical Researches about u-Maximal Subgroups and Its Applications in Charactering IntuG

open access: yesJournal of Chemistry, 2019
Let G be a finite group and u be the class of all finite supersoluble groups. A supersoluble subgroup U of G is called u-maximal in G if for any supersoluble subgroup V of G containing U, V=U.
Li Zhang, Zheng-Qun Cai
doaj   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo   +9 more
wiley   +1 more source

Finite groups with partially σ-subnormal subgroups in short maximal chains [PDF]

open access: yesAdvances in Group Theory and Applications, 2021
Viktoria S. Zakrevskaya
doaj   +1 more source

Maximal subgroups of groups of intermediate growth [PDF]

open access: green, 2018
Dominik Francoeur, Alejandra Garrido
openalex   +1 more source

Home - About - Disclaimer - Privacy